Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006-2017).

Silvia Portero de la Cruz, Jesús Cebrino
Author Information
  1. Silvia Portero de la Cruz: Department of Nursing, Pharmacology and Physiotherapy, Faculty of Medicine and Nursing, University of Córdoba, Avda. Menéndez Pidal, S/N, 14071 Córdoba, Spain. ORCID
  2. Jesús Cebrino: Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Seville, Avda. Doctor Fedriani, S/N, 41009 Seville, Spain. ORCID

Abstract

Influenza is a significant public health problem and the elderly are at a greater risk of contracting the disease. The vaccination coverage of the elderly is below the Spanish target of 65% for each influenza season. The aims of this study were to report the coverage of influenza vaccination in Spain among the population aged ≥65 years and high-risk groups for suffering chronic diseases, to analyze the time trends from 2006 to 2017 and to identify the factors which affect vaccination coverage. A nationwide cross-sectional study was conducted including 20,753 non-institutionalized individuals aged ≥65 years who had participated in the Spanish National Health Surveys in 2006, 2011/2012, and 2017. Sociodemographic, health-related variables, and influenza vaccination data were used. A logistic regression analysis was performed to determine the variables associated with influenza vaccination. Influenza vaccination coverage was 60%. By chronic condition, older people with high cholesterol levels and cancer had the lowest vaccination coverage (62.41% and 60.73%, respectively). This coverage declined from 2006 to 2017 in both groups. Higher influenza vaccination was associated with males, Spanish nationality, normal social support perceived, polypharmacy, worse perceived health, participation in other preventive measures, and increasing age and the number of chronic diseases.

Keywords

References

  1. BMC Public Health. 2016 Feb 04;16:121 [PMID: 26846202]
  2. Health Promot Int. 2020 Feb 27;: [PMID: 32105311]
  3. PLoS One. 2016 Jan 29;11(1):e0147931 [PMID: 26824383]
  4. Vaccine. 2016 Sep 22;34(41):4898-4904 [PMID: 27595448]
  5. Prev Med. 2007 Nov;45(5):373-9 [PMID: 17707499]
  6. Euro Surveill. 2018 Feb;23(8): [PMID: 29486829]
  7. Cochrane Database Syst Rev. 2018 Feb 01;2:CD008983 [PMID: 29388675]
  8. J Infect Dis. 2017 Aug 15;216(4):405-414 [PMID: 28931244]
  9. Disabil Health J. 2017 Jan;10(1):48-57 [PMID: 27765676]
  10. Appl Health Econ Health Policy. 2017 Feb;15(1):13-21 [PMID: 27461007]
  11. Cien Saude Colet. 2016 Nov;21(11):3429-3438 [PMID: 27828576]
  12. Gac Sanit. 2014 Jul-Aug;28(4):281-6 [PMID: 24698034]
  13. Vaccine. 2017 Dec 18;35(51):7095-7100 [PMID: 29122385]
  14. Int J Environ Res Public Health. 2017 Jun 20;14(6): [PMID: 28632192]
  15. Eur Geriatr Med. 2018;9(3):289-300 [PMID: 29887922]
  16. J Mark Access Health Policy. 2015 Aug 12;3: [PMID: 27123182]
  17. Drugs Context. 2016 Aug 03;5:212293 [PMID: 27540408]
  18. Aten Primaria. 1996 Sep 15;18(4):153-6, 158-63 [PMID: 8962994]
  19. Public Health. 2018 Mar;156:67-78 [PMID: 29408191]
  20. BMC Geriatr. 2017 Aug 29;17(1):194 [PMID: 28851282]
  21. PeerJ. 2018 Jul 13;6:e5171 [PMID: 30013841]
  22. Vaccine. 2018 Mar 7;36(11):1467-1476 [PMID: 29426662]
  23. Gac Sanit. 2013 May-Jun;27(3):263-72 [PMID: 23394892]
  24. PLoS One. 2016 Sep 29;11(9):e0163508 [PMID: 27684558]
  25. Aten Primaria. 1991 Oct;8(9):688-92 [PMID: 16989055]
  26. Euro Surveill. 2018 Oct;23(43): [PMID: 30376915]
  27. Disaster Med Public Health Prep. 2019 Jun;13(3):582-592 [PMID: 31328711]
  28. BMC Public Health. 2015 Jul 07;15:618 [PMID: 26148480]
  29. Vaccine. 2019 Jul 26;37(32):4454-4459 [PMID: 31277956]
  30. Vaccine. 2015 Nov 27;33(48):6537-44 [PMID: 26597032]
  31. Rev Med Virol. 2019 Jan;29(1):e2014 [PMID: 30408280]
  32. CMAJ Open. 2016 Aug 19;4(3):E455-E462 [PMID: 27975047]
  33. Cochrane Database Syst Rev. 2014 Jul 07;(7):CD005188 [PMID: 24999919]
  34. Vaccine. 2020 Apr 3;38(16):3243-3254 [PMID: 32171573]
  35. Aging Clin Exp Res. 2019 Oct 12;: [PMID: 31606859]
  36. Adv Exp Med Biol. 2017;968:19-34 [PMID: 28315129]
  37. Eur J Public Health. 2015 Dec;25(6):923-9 [PMID: 26136466]
  38. PLoS One. 2018 Sep 7;13(9):e0202787 [PMID: 30192781]
  39. J Am Med Inform Assoc. 2015 Jan;22(1):243-56 [PMID: 25005606]
  40. Hum Vaccin Immunother. 2020;16(1):95-99 [PMID: 31339794]
  41. Aten Primaria. 2016 Feb;48(2):110-20 [PMID: 26014888]
  42. Tuberc Respir Dis (Seoul). 2018 Jul;81(3):187-197 [PMID: 29962118]
  43. J Public Health (Oxf). 2016 Dec 02;38(4):746-753 [PMID: 28158550]
  44. BMC Geriatr. 2017 Oct 10;17(1):230 [PMID: 29017448]
  45. Euro Surveill. 2014 Apr 24;19(16):20780 [PMID: 24786262]
  46. Viral Immunol. 2016 Nov;29(9):516-525 [PMID: 27509083]
  47. Med Care. 1988 Jul;26(7):709-23 [PMID: 3393031]
  48. Vaccine. 2015 Mar 30;33(14):1682-7 [PMID: 25720791]
  49. Hum Vaccin Immunother. 2015;11(1):198-205 [PMID: 25483536]
  50. Cochrane Database Syst Rev. 2018 Jun 26;6:CD002733 [PMID: 29943802]
  51. Health Educ Res. 2015 Oct;30(5):706-18 [PMID: 26336905]
  52. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E31-E37 [PMID: 31016265]
  53. Pharmacoeconomics. 2016 Aug;34(8):723-31 [PMID: 26914091]
  54. Prev Med. 2019 Sep;126:105734 [PMID: 31152830]
  55. Gerontology. 2015;61(5):469-76 [PMID: 25660128]
  56. Am J Infect Control. 2015 Nov;43(11):1161-5 [PMID: 26521933]
  57. BMJ Open. 2016 Dec 28;6(12):e012618 [PMID: 28031209]
  58. Vaccine. 2017 Dec 18;35(51):7154-7159 [PMID: 29126805]
  59. Prev Med Rep. 2015 Sep 21;2:803-8 [PMID: 26844153]
  60. Health Rep. 2018 Oct 17;29(10):12-22 [PMID: 30329145]
  61. BMC Obes. 2016 May 03;3:24 [PMID: 27200179]
  62. Colomb Med (Cali). 2016 Mar 30;47(1):25-30 [PMID: 27226661]
  63. Vaccine. 2016 Apr 19;34(18):2135-40 [PMID: 26917011]
  64. Ethn Health. 2015;20(6):611-32 [PMID: 25411892]
  65. Am J Infect Control. 2015 May 1;43(5):e1-5 [PMID: 25798776]
  66. Vaccine. 2018 Jan 25;36(4):442-452 [PMID: 29287683]
  67. PLoS One. 2015 Apr 13;10(4):e0123840 [PMID: 25874953]
  68. PLoS One. 2016 Nov 30;11(11):e0166359 [PMID: 27902720]
  69. MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):634-642 [PMID: 29879098]
  70. PLoS One. 2017 Jan 26;12(1):e0170550 [PMID: 28125629]
  71. BMC Health Serv Res. 2018 Jan 18;18(1):30 [PMID: 29347933]

Word Cloud

Created with Highcharts 10.0.0vaccinationcoverageinfluenzaInfluenzaSpanishagedchronic20062017healthelderlystudySpain≥65yearsgroupsdiseasestrendsNationalvariablesassociatedperceivedsignificantpublicproblemgreaterriskcontractingdiseasetarget65%seasonaimsreportamongpopulationhigh-risksufferinganalyzetimeidentifyfactorsaffectnationwidecross-sectionalconductedincluding20753non-institutionalizedindividualsparticipatedHealthSurveys2011/2012Sociodemographichealth-relateddatausedlogisticregressionanalysisperformeddetermine60%conditionolderpeoplehighcholesterollevelscancerlowest6241%6073%respectivelydeclinedHighermalesnationalitynormalsocialsupportpolypharmacyworseparticipationpreventivemeasuresincreasingagenumberTrendsCoverageInfluencingDeterminantsVaccinationElderly:Population-BasedSurvey2006-2017humanvaccines

Similar Articles

Cited By